Evidence map›Paper›PMID 35410125›Full record

ArticleBMC microbiology2022

Skin microbiome alters attractiveness to Anopheles mosquitoes.

Alicia Showering, Julien Martinez, Ernest Diez Benavente, Salvador A Gezan, Robert T Jones, Catherine Oke, Scott Tytheridge, Elizabeth Pretorius, Darren Scott, Rachel L Allen and 5 more

Open access · goldAbstract read
In one paragraph

Article in BMC microbiology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
4.4field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 25 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 9 institutions in 3 countries.

Alicia ShoweringDepartment of Disease Control, London School of Hygiene & Tropical Medicine, London, UK. Alicia.showering1@lshtm.ac.uk.ORCID 0000-0003-1025-8593
Julien MartinezMRC-University of Glasgow Centre for Virus Research, University of Glasgow, 464 Bearsden Road, Glasgow, G61 1QH, UK.
Ernest Diez BenaventeDepartment of Experimental Cardiology, University Medical Center Utrecht, Utrecht, the Netherlands.
Salvador A GezanVSN International Ltd, Hemel Hempstead, Hertfordshire, UK.
Robert T JonesDepartment of Disease Control, London School of Hygiene & Tropical Medicine, London, UK.
Catherine OkeDepartment of Disease Control, London School of Hygiene & Tropical Medicine, London, UK.
Scott TytheridgeDepartment of Disease Control, London School of Hygiene & Tropical Medicine, London, UK.
Elizabeth PretoriusDepartment of Disease Control, London School of Hygiene & Tropical Medicine, London, UK.
Darren ScottDepartment of Medical Statistics, London School of Hygiene & Tropical Medicine, London, UK.
Rachel L AllenInstitute for Infection and Immunity, St George's, University of London, London, UK.
Umberto D'AlessandroMedical Research Council Unit The Gambia at the London School of Hygiene and Tropical Medicine, Fajara, Gambia.
Steve W LindsayDepartment of Biosciences, University of Durham, Durham, UK.
John A L ArmourSchool of Life Sciences, University of Nottingham, Queen's Medical Centre, Nottingham, UK.
John PickettSchool of Chemistry, Cardiff University, Cardiff, Wales, UK.
James G LoganDepartment of Disease Control, London School of Hygiene & Tropical Medicine, London, UK.
London School of Hygiene & Tropical Medicine · GBCardiff University · GBDurham University · GBMRC Unit the Gambia · GMMRC University of Glasgow Centre for Virus Research · GBSt George's, University of London · GBUniversity Medical Center Utrecht · NLUniversity of Nottingham · GBVSN International (United Kingdom) · GB

Funding

Medical Research Council MC_UU_12014/8Medical Research Council MR/P021972/1
6 · The paper itself

Abstract

backgroundSome people produce specific body odours that make them more attractive than others to mosquitoes, and consequently are at higher risk of contracting vector-borne diseases. The skin microbiome can break down carbohydrates, fatty acids and peptides on the skin into volatiles that mosquitoes can differentiate.

resultsHere, we examined how skin microbiome composition of women differs in relation to level of attractiveness to Anopheles coluzzii mosquitoes, to identify volatiles in body odour and metabolic pathways associated with individuals that tend to be poorly-attractive to mosquitoes. We used behavioural assays to measure attractiveness of participants to An. coluzzii mosquitoes, 16S rRNA amplicon sequencing of the bacteria sampled from the skin and gas chromatography of volatiles in body odour. We found differences in skin microbiome composition between the poorly- and highly-attractive groups, particularly eight Amplicon Sequence Variants (ASVs) belonging to the Proteobacteria, Actinobacteria and Firmicutes phyla. Staphylococcus 2 ASVs are four times as abundant in the highly-attractive compared to poorly-attractive group. Associations were found between these ASVs and volatiles known to be attractive to Anopheles mosquitoes. Propanoic pathways are enriched in the poorly-attractive participants compared to those found to be highly-attractive.

conclusionsOur findings suggest that variation in attractiveness of people to mosquitoes is related to the composition of the skin microbiota, knowledge that could improve odour-baited traps or other next generation vector control tools.

Indexed as

AnophelesMicrobiotaAnimalsBacteriaFemaleHumansMosquito VectorsOdorantsRNA, Ribosomal, 16SRNA, Ribosomal, 16SAnopheles coluzziiBody odourDiversityHuman attractivenessMalariaMosquitoesRepellentsSkin microbiome

Identifiers

PMID35410125
PMCPMC9004177
OpenAlexW4223466648

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.